Record #341858 - GSI Repository

MAGIC

Minimally invasive reliAble Glucose monitoring in Intensive Care

Grant period	2022-12-01 - 2024-09-30
Funding body	European Union
Call number	HORIZON-EIC-2022-ACCELERATOR-01
Grant number	190140677
Identifier	G:(EU-Grant)190140677

Note: 9 of 10 intensive care unit (ICU) patients get elevated glucose levels because of their critical illness. Clinical trials prove that better glucose control could save thousands of lives and millions of euros for hospitals. Surprisingly, no continuous glucose monitor (CGM) is available for ICU patients, as solutions developed for diabetics don't work in the ICU. GlucoSet has a novel, patented technology for glucose monitoring. This enables - for the first time - reliable, minimally invasive, real-time monitoring of glucose in ICU patients. 4 of 5 EU ICU physicians say our product would be "very valuable" in their ICU and believe it will improve outcomes in their ICU. 9 of 10 ICU managers say they are willing to pay for use in a large share of their patients on launch. A demo version of the product has been tested in patients with excellent results (TRL6). This project aims to make the product ready for CE-mark (TRL8) in 22 months, then validate clinical benefits, and scale up (TRL9).

Recent Publications

There are no publications

Record created 2023-08-27, last modified 2023-08-27

Similar records

Add to personal basket
Export as Author List with IDs BibTeX (UTF-8), EndNote XML, EndNote Text, RIS, MARC, Print MARC, MARCXML, DC,
Request correction
Submit fulltext

GSI Homepage \| GSI Library \| English Deutsch \| guest :: login GSI Repository
Search	Submit	Personalize Your alerts Your baskets Your searches	Help